Davis Rea LTD. purchased a new position in CannTrust Holdings Inc (NYSE:CTST) in the 1st quarter, HoldingsChannel.com reports. The firm purchased 496,135 shares of the company’s stock, valued at approximately $3,846,000. CannTrust comprises approximately 2.3% of Davis Rea LTD.’s holdings, making the stock its 20th biggest position.
Several research analysts recently issued reports on the stock. Zacks Investment Research lowered shares of CannTrust from a “buy” rating to a “hold” rating in a research note on Wednesday, April 3rd. Bloom Burton reiterated an “accumulate” rating on shares of CannTrust in a research note on Friday, March 29th.
CTST stock traded down C$0.44 during trading on Thursday, hitting C$7.03. 2,261,426 shares of the stock traded hands, compared to its average volume of 1,165,646. CannTrust Holdings Inc has a 1 year low of C$4.35 and a 1 year high of C$11.97. The company has a market capitalization of $789.13 million, a price-to-earnings ratio of -63.91 and a beta of 4.40. The company has a debt-to-equity ratio of 0.06, a quick ratio of 5.54 and a current ratio of 7.65.
CannTrust Company Profile
CannTrust Holdings Inc produces and distributes pharmaceutical grade medical cannabis products in Canada. It sells dried cannabis and oil extractions to the client based on the medication document provided by health care practitioner. The company has a partnership with Gold Coast University Hospital.
See Also: Trade Deficit
Want to see what other hedge funds are holding CTST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CannTrust Holdings Inc (NYSE:CTST).
Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with MarketBeat.com's FREE daily email newsletter.